Chubb: Sufficiently Cheap To Buy After A Solid Q2 (Rating Upgrade)

Chubb (NYSE:CB) reported a robust Q2, with EPS of $6.14, a 14% increase, and record P&C underwriting income of $1.63 billion, driven by an impressive 85.6% combined ratio. This strong performance, underpinned by disciplined underwriting, strategic capital allocation to high-return segments, and an 8% rise in net investment income, has alleviated some concerns about peaking profitability. Consequently, the analyst upgraded Chubb to "buy," citing its ability to sustain underwriting margins, a revised 2024 EPS forecast of $21-$22, and a $300 fair value, presenting an attractive entry point for investors despite recent share underperformance.

Analysis

Chubb (CB) delivered a strong second-quarter performance that directly addresses concerns over peaking underwriting profitability, leading to a ratings upgrade from 'hold' to 'buy'. The company reported earnings of $6.14 per share, a 14% year-over-year increase that beat estimates by $0.17, driven by a record P&C underwriting income of $1.63 billion. A key highlight was the improved combined ratio, which fell 120 basis points to 85.6%, signifying a superior 14.4% underwriting margin and outperformance relative to peers. This result was supported by the company's strategic shift toward more favorably priced segments, with personal lines and middle-market business in North America growing 9% and 8.5% respectively, while growth in the more competitive large-account space was a muted 1.2%. The investment portfolio also contributed positively, with net investment income rising 8% to $1.7 billion, and its 4.8-year duration is expected to keep the book yield above 5% through 2027. While premium inflation has decelerated, suggesting margin expansion is largely complete, the company is positioned to sustain current profitability levels, with future growth more closely linked to premium volumes. The analyst's fair value has been raised to $300 based on a normalized earnings power of ~$25.00, implying a total return potential of approximately 10% when factoring in dividends and buybacks.

Key Decisions for Investors

• Given the stock's recent underperformance relative to the market, the strong Q2 results and analyst upgrade to 'buy' with a $300 price target suggest an attractive entry point into a high-quality insurer.
• Investors should monitor P&C premium growth trends closely, as the analysis indicates this will be the primary driver of profit growth now that the margin recapture cycle appears to be ending.
• While the outlook is positive, downside risks remain from a potentially active U.S. hurricane season impacting catastrophe losses and any re-escalation of U.S.-China geopolitical tensions affecting the valuation of its Chinese life insurance unit.
• The newly authorized $5 billion share buyback program and a 6.6% dividend increase provide a solid foundation for total shareholder return and can offer downside support for the stock.